封面
市场调查报告书
商品编码
1663035

透明质酸基真皮填充剂市场规模、份额、成长分析、按产品、应用、最终用户、地区 - 产业预测,2025 年至 2032 年

Hyaluronic Acid Based Dermal Fillers Market Size, Share, and Growth Analysis, By Product (Single Phase Products, Duplex Products), By Application (Wrinkle Removal, Lip Augmentation), By End-User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023 年全球基于透明质酸的真皮填充剂市场规模价值 46 亿美元,预计将从 2024 年的 50.2 亿美元增长到 2032 年的 100.7 亿美元,预测期内(2025-2032 年)的复合年增长率为 9.1%。

受非侵入性手术需求的不断增长以及对透明质酸 (HA) 在美容领域应用的认识不断提高的推动,美容市场正在经历显着增长。研发投入的增加推动了皮肤产品的创新。一个显着的趋势是,男性对美容疗程的兴趣日益浓厚,他们积极寻求解决方案来对抗老龄化的影响,从而导致脸部填充剂的需求激增。技术进步,例如 2021 年引入的高效雷射表面置换治疗,是为了回应人们对微创治疗的偏好。随着美国美国食品药物管理局(FDA)核准RHA Redensity 等新产品,市场儘管面临监管挑战,但仍提供了机会,并继续保持强劲的成长轨迹,以满足不断变化的消费者需求。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管分析
  • 案例研究

透明质酸类真皮填充剂市场规模(依产品划分)

  • 市场概况
  • 单相产品
  • 双相产品

透明质酸类真皮填充剂市场规模(依应用)

  • 市场概况
  • 除皱
  • 丰唇
  • 鼻整形手术
  • 其他的

透明质酸类真皮填充剂市场规模(以最终用户划分)

  • 市场概况
  • 医院
  • 皮肤科专科诊所
  • 化妆品中心

透明质酸类真皮填充剂市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司详细信息
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • AbbVie Inc.(USA)
  • Galderma SA(Switzerland)
  • Merz Pharma GmbH & Co. KGaA(Germany)
  • LG Chem Ltd.(South Korea)
  • Bloomage Biotechnology Corp. Ltd.(China)
  • Teoxane SA(Switzerland)
  • Croma-Pharma GmbH(Austria)
  • Hugel, Inc.(South Korea)
  • Revance Therapeutics, Inc.(USA)
  • Prollenium Medical Technologies Inc.(Canada)
  • Anika Therapeutics, Inc.(USA)
  • Suneva Medical, Inc.(USA)
  • BioPlus Co., Ltd.(South Korea)
  • Bioxis Pharmaceuticals(France)
  • Bohus Biotech AB(Sweden)
  • Laboratoires Vivacy(France)
  • Medytox Inc.(South Korea)
  • Symatese(France)
  • Dr. Korman Laboratories Ltd.(Israel)
  • Sculpt Luxury Dermal Fillers Ltd.(UK)

结论和建议

简介目录
Product Code: SQMIG35H2096

Global Hyaluronic Acid Based Dermal Fillers Market size was valued at USD 4.6 billion in 2023 and is poised to grow from USD 5.02 billion in 2024 to USD 10.07 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The aesthetic market is witnessing significant growth fueled by a rising demand for non-invasive procedures and heightened awareness of Hyaluronic Acid (HA) applications in beauty. Increased investment in research and development is driving innovation in dermal products. A notable trend is the growing interest in aesthetic treatments among men, who are actively seeking solutions to counteract aging effects, resulting in a surge in demand for facial fillers. Technological advancements, such as the introduction of an efficient laser resurfacing treatment in 2021, are catering to the preference for less invasive options. With new product approvals, including RHA Redensity by the U.S. FDA, the market presents opportunities despite regulatory challenges, maintaining a robust growth trajectory in response to evolving consumer needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyaluronic Acid Based Dermal Fillers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hyaluronic Acid Based Dermal Fillers Market Segments Analysis

Global Hyaluronic Acid Based Dermal Fillers Market is segmented by Product, Application, End-User and region. Based on Product, the market is segmented into Single Phase Products and Duplex Products. Based on Application, the market is segmented into Wrinkle Removal, Lip Augmentation, Rhinoplasty and Others. Based on End-User, the market is segmented into Hospitals, Specialty Dermatology Clinics and Cosmetic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hyaluronic Acid Based Dermal Fillers Market

A significant factor propelling the Global Hyaluronic Acid Based Dermal Fillers Market is the rising demand for non-invasive cosmetic procedures. This surge in demand is driven by various elements, including heightened consumer awareness about aesthetic options, an increasing desire among individuals to maintain a youthful look, and continuous technological advancements in hyaluronic acid treatments. The growing popularity of these procedures is not only stimulating market growth but also creating new opportunities for industry participants to innovate and expand their offerings, ultimately enhancing their positions within the competitive landscape.

Restraints in the Global Hyaluronic Acid Based Dermal Fillers Market

A significant challenge facing the Global Hyaluronic Acid Based Dermal Fillers Market is the elevated costs linked to surgical procedures. Although there is an increasing demand for aesthetic treatments, the expense can deter potential clients, limiting their ability to access such services. This financial barrier may inhibit market expansion, especially in areas where many individuals struggle with affordability and accessibility. Consequently, the high price point of these treatments poses a restraint on market growth, potentially preventing a broader demographic from benefiting from hyaluronic acid-based solutions and impacting overall market dynamics in regions with economic constraints.

Market Trends of the Global Hyaluronic Acid Based Dermal Fillers Market

The Global Hyaluronic Acid Based Dermal Fillers market is increasingly witnessing a trend towards the integration of lidocaine, a local anesthetic, into HA-based fillers, aimed at enhancing patient comfort during aesthetic procedures. This innovation addresses the growing consumer demand for pain-free experiences, reflecting a broader industry shift towards patient-centric approaches. Companies are recognizing this need and are strategically developing HA fillers that prioritize comfort, thus improving overall treatment satisfaction and outcomes. As this trend continues to gain traction, it is likely to further drive the popularity of hyaluronic acid fillers, reinforcing their position in the aesthetic market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis
  • Case Studies

Global Hyaluronic Acid Based Dermal Fillers Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Single Phase Products
  • Duplex Products

Global Hyaluronic Acid Based Dermal Fillers Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Wrinkle Removal
  • Lip Augmentation
  • Rhinoplasty
  • Others

Global Hyaluronic Acid Based Dermal Fillers Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Specialty Dermatology Clinics
  • Cosmetic Centers

Global Hyaluronic Acid Based Dermal Fillers Market Size & CAGR (2025-2032)

  • North America (Product, Application, End-User)
    • US
    • Canada
  • Europe (Product, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • AbbVie Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Galderma S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Pharma GmbH & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LG Chem Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloomage Biotechnology Corp. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teoxane SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Croma-Pharma GmbH (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hugel, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revance Therapeutics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prollenium Medical Technologies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Suneva Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioPlus Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioxis Pharmaceuticals (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bohus Biotech AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratoires Vivacy (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medytox Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Symatese (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Korman Laboratories Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sculpt Luxury Dermal Fillers Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations